The Montreal Neurological Institute-Hospital, also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada.

There are 85 beds in Recherche Clinique de Neurologie.

During the past decade, Recherche Clinique de Neurologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Recherche Clinique de Neurologie" are "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Recherche Clinique de Neurologie" in a lesser frequency.

Most popular intervention types in "Recherche Clinique de Neurologie" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-04360365 0.1 mg/kg" (1 trials), "PF-04360365 0.5 mg/kg" (1 trials), "PF-04360365 1 mg/kg" (1 trials), "PF-04360365 3 mg/kg" (1 trials) and "PF-04360365 8.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Recherche Clinique de Neurologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Recherche Clinique de Neurologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Recherche Clinique de Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Recherche Clinique de Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".